Intraventricular administration of rt-PA in patients with intraventricular hemorrhage

Southern Medical Journal

Volumn 98, Issue 8, 2005, Pages 767-773

  Fountas, Kostas N ^a,b   Kapsalaki, E Z ^a   Parish, D C ^a   Smith, B ^a   Smisson, H F ^a   Johnston, K W ^a   Robinson, J S ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Hydrocephalus; Infection; Intraventricular hemorrhage; Outcome; rt PA

Indexed keywords

ALTEPLASE; STREPTOKINASE; UROKINASE;

ADULT; AGED; ARTERIOVENOUS MALFORMATION; ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN HEMORRHAGE; BRAIN INFECTION; BRAIN PERFUSION; CEREBROSPINAL FLUID CYTOLOGY; CEREBROSPINAL FLUID SHUNTING; COMPUTER ASSISTED TOMOGRAPHY; DISABILITY; FEMALE; HUMAN; HYDROCEPHALUS; MALE; PERFUSION PRESSURE; PLEOCYTOSIS; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; CEREBRAL HEMORRHAGE; CEREBRAL VENTRICLES; FEMALE; HUMANS; HYDROCEPHALUS; INJECTIONS, INTRAVENTRICULAR; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATORS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; VENTRICULOSTOMY;

EID: 24144472257     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000170732.24324.ea     Document Type: Article

References (40)

1. Andrews CO, Engelhard HH. Fibrinolytic therapy in intraventricular hemorrhage. Ann Pharmacol 2001;35:1435-1447.
2. Darby DG, Donnan GA, Saling MA, et al. Primary intraventricular hemorrhage: clinical and neurophysiological findings in a prospective stroke series. Neurology 1988;38:68-75.
3. Little JR, Blomquist CA, Ethier R. Intraventricular hemorrhage in adults. Surg Neurol 1977;8:143-149.
4. Lee MWY, Pang KY, Ho WWS, et al. Outcome analysis of intraventricular thrombolytic therapy for intraventricular haemorrhage. Hong Kong Med J 2003;9:335-340.
5. Todo T, Usui M, Takakura K. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. J Neurosurg 1991;74: 81-86.
6. Graeb DA, Robertson WD, Lapointe JS, et al. Computed tomographic diagnosis of intraventricular hemorrhage: etiology and prognosis. Radiology 1982;143:91-96.
7. Ikeda Y, Nakazawa S, Higuchi H, et al. Clinical aspects and prognosis of intraventricular hemorrhage with cerebrovascular disease: CT findings and etiological analysis. Neurol Med Chir 1982;22:822-828.
8. Ruscalleda J, Peiro A. Prognostic factors in intraparenchymatous hematoma with ventricular hemorrhage. Neuroradiology 1986;28:34-37.
9. Pang D, Sclabassi RJ, Horton JA. Lysis of intraventricular blood clot with urokinase in a canine model: part 3. Neurosurgery 1986;19:553-572.
10. Mayer SL, Kessler RL. Effect of intraventricular blood on global cortical perfusion in acute intracerebral hemorrhage: a single photon emission computed tomographic study (abstract). Ann Neurol 1995;38:228.
11. Keller TM, Corkill G, Ellis WG. Persistent isodense intraventricular hematoma caused by intraventricular saccular aneurysm. Surg Neurol 1980;13:177-180.
12. Yamamoto Y, Waga S. Persistent intraventricular hematoma following ruptured aneurysm. Surg Neurol 1982;17:301-303.
13. Shapiro SA, Campbell RL, Scully T. Hemorrhagic dilation on the fourth ventricle: an ominous predictor. J Neurosurg 1994;80:805-809.
14. Goh KYC, Poon WS. Recombinant tissue plasminogen activator for the treatment of spontaneous adult intraventricular hemorrhage. Surg Neurol 1998;50:526-532.
15. Mayfrank L, Kissler J, Raoofi R, et al. Ventricular dilatation in experimental intraventricular hemorrhage in pigs. Stroke 1997;28:141-148.
16. Haines SJ, Lapointe M. Fibrinolytic agents in the treatment of intraventricular hemorrhage in adults. Crit Rev Neurosurg 1998;8:169-175.
17. Findlay JM, Grace MGA, Weir BKA. Treatment of intraventricular hemorrhage with tissue plasminogen activator. Neurosurg 1993;6:941-947.
18. Deutsch H, Rodriguez JC, Titton RL. Lower dose intraventricular t-PA fibrinolysis: case report. Surg Neurol 2004;61:460-463.
19. Shen PH, Matsuoka Y, Kawajiri K, et al. Treatment of intraventricular hemorrhage using urokinase. Neurol Med Chir (Tokyo) 1990;30:329-333.
20. Tung MYY, Ong PL, Seow WT, et al. A study on the efficacy of intraventricular urokinase in the treatment of intraventricular haemorrhage. Br J Neurosurg 1998;12:234-239.
21. Naff NJ, Hanley DF, Keyl PM, et al. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurg 2004;54:577-584.
22. Naff NJ, Carhuapoma JR, Williams MA, et al. Treatment of intraventricular hemorrhage with urokinase: effects on 30-day survival. Stroke 2000;31:841-847,
23. Coplin WM, Vinas FC, Agris JM, et al. A cohort study of the safety and feasibility of intraventricular urokinase for non-aneurysmal spontaneous intraventricular hemorrhage. Stroke 1998;29:1573-1579.
24. Murry KR, Rhoney DH, Coplin WM. Urokinase in the treatment of intraventricular hemorrhage. Ann Pharmacol 1998;32:256-258.
25. Rainov NG, Burkert WL. Urokinase infusion for severe intraventricular haemorrhage. Acta Neurochir 1995;134:55-59.
26. Mayfrank L, Lippitz B, Groth M, et al. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilation in the treatment of severe intraventricular haemorrhage. Acta Neurochir 1993;122: 32-38.
27. de Weerd AW. The prognosis of intraventricular hemorrhage. J Neurol 1979;222:45-51.
28. LeRoux PD, Haglund MM, Newell DW, et al. Intraventricular hemorrhage in blunt head trauma: an analysis of 43 cases. Neurosurgery 1992; 31:678-685.
29. Tuhrim S, Horowitz DR, Sacher M, et al. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 1999;27:617-621.
30. Narayan RK, Narayan TM, Katz DA, et al. Lysis of intracranial hematomas with urokinase in a rabbit model. J Neurosurg 1985;62:580-586.
31. Hudgins RJ, Boydston WR, Hudgins PA, et al. Intrathecal urokinase as a treatment for intraventricular hemorrhage in the preterm infant. Pediatr Neurosurg 1997;26:281-287.
32. Hudgins RJ, Boydston WR, Gilreath CL. Treatment of posthemorrhagic hydrocephalus in the preterm infant with a ventricular access device. Pediatr Neurosurg 1998;29:309-313.
33. Stolke D, Seifert V. Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study. Neurosurgery 1992;30:877-881.
34. Usui M, Saito N, Hoya K, et al. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Neurosurgery 1994;34:235-245.
35. Pang D, Sclabassi RJ, Horton JA. Lysis of intraventricular blood clot with urokinase in a canine model: part 2. Neurosurgery 1986;19:547-552.
36. Hansen AR, Volpe JJ, Goumnerova LC, et al. Intraventricular urokinase for the treatment of posthemorrhagic hydrocephalus. Pediatr Neurol 1997;17:213-217.
37. Hansen A, Whitelaw A. Lapp C, et al. Cerebrospinal fluid plasminogen activator inhibitor-1: a prognostic factor in posthaemorrhagic hydrocephalus. Acta Pediatr 1997;86:995-998.
38. Rohde V, Schaller C, Hassler WE. Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage. J Neurol Neurosurg Psychiatry 1995;58:447-451.
39. Wang YC, Lin CW, Shen CC, et al. Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose-effect relationship. J Neurol Sci 2002;202:35-41.
40. Schwarz S, Schwab S, Steiner HH, et al. Secondary hemorrhage after intraventricular fibrinolysis: a cautionary note: a report of two cases. Neurosurgery 1998;42:659-663.